Repligen (RGEN) Debt to Equity (2013 - 2026)

Repligen (RGEN) reported Debt to Equity of $0.0 for Q1 2026, down 85.45% year-over-year from $0.02 in Q1 2025, and up 3.54% quarter-over-quarter from $0.0 in Q4 2025.

Repligen (RGEN) Debt to Equity (2013 - 2026) Analysis & Trends

Repligen (RGEN) has 9 years of Debt to Equity data on file, last reported at $0.0 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.0, down 85.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.0 (down 85.45% YoY), and the FY2025 annual result was $0.0, down 72.39% from the prior year.
  • Debt to Equity rose to $0.0 in Q1 2026 per RGEN's latest filing, from $0.0 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.02 in Q1 2025 and troughed at $0.0 in Q4 2025.
  • A 5-year average of $0.01 and a median of $0.01 in 2022 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2025 and 2026: Debt to Equity surged 37.67% in 2025, then sank 85.45% in 2026.
  • A 5-year view of Debt to Equity shows it stood at $0.01 in 2022, then retreated by 9.5% to $0.01 in 2023, then surged by 31.38% to $0.01 in 2024, then tumbled by 72.39% to $0.0 in 2025, then gained by 3.54% to $0.0 in 2026.
  • Business Quant data shows RGEN's Debt to Equity at $0.0 in Q1 2026, $0.0 in Q4 2025, and $0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 0.72
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 1.12
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 0.04
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 0.07
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 1.02
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 0.30
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 1.57
10 Repligen 7.41 Bn 6.42 Bn 108.28 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.02
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.02
Dec 31, 2016 0.04
Sep 30, 2016 0.04
Jun 30, 2016 0.04